Related Experiment Video

Updated: Jul 13, 2026

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome?

Julian Segura1, Jose Ramon Banegas, Jose Antonio García-Donaire

  • 1Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid, Spain. hta@juliansegura.com

Journal of Clinical Hypertension (Greenwich, Conn.)
|August 4, 2007
PubMed

Insights

Hypertension management guidelines improved cardiovascular risk factors in patients with metabolic syndrome (MS). However, MS patients still face higher risks, including a threefold increased incidence of new-onset diabetes.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Hypertension Management

Background:

  • Metabolic syndrome (MS) significantly elevates cardiovascular (CV) risk factors in hypertensive patients.
  • Current hypertension management guidelines aim to mitigate CV risk in diverse patient populations.

Purpose of the Study:

  • To assess the impact of current hypertension management guidelines on CV risk factors in hypertensive patients with and without metabolic syndrome (MS).
  • To compare the progression of CV risk factors and incidence of comorbidities between hypertensive patients with and without MS under standard care.

Main Methods:

  • Retrospective analysis of 549 nondiabetic hypertensive patients over a mean follow-up of 3.8 years.
  • Patients were categorized at baseline based on the presence (MS) or absence (non-MS) of metabolic syndrome.
  • Evaluation of blood pressure, lipid profile, microalbuminuria, and new-onset diabetes as primary outcomes.

Main Results:

  • Both MS and non-MS groups achieved similar blood pressure and LDL cholesterol goals.
  • MS patients showed a tendency towards lipid profile improvement.
  • A significantly higher incidence of new-onset diabetes (7.8% vs 2.2%) and persistent higher microalbuminuria was observed in MS patients.
  • Global CV risk remained elevated in MS patients despite guideline adherence.

Conclusions:

  • Standard hypertension care effectively manages blood pressure and LDL cholesterol in patients with and without MS.
  • Metabolic syndrome remains a significant independent predictor of adverse cardiovascular outcomes, including higher diabetes and microalbuminuria incidence.
  • Further risk stratification and tailored interventions are crucial for hypertensive patients with MS.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...